Stock listing
Arcus Biosciences, Inc.
Selected listing: RCUS · NYSE · USD · US
Arcus Biosciences, Inc. (NYSE:RCUS), Health Technology. Latest release Sep 22, 2026: Arcus Biosciences to Host Investor Event Featuring New Data…
- Ticker
- NYSE:RCUS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
About Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, focusing on innovative cancer therapies. The company aims to improve treatment options for patients through its cutting-edge approaches in oncology.
Latest news from Arcus Biosciences, Inc.
Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy
September 22, 2026
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
August 5, 2026
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
July 22, 2026
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
July 22, 2026
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
July 21, 2026
Events
Research Arcus Biosciences, Inc.
Arcus Biosciences, Inc. company profile
View the public company page for Arcus Biosciences, Inc. on 6ix.
Arcus Biosciences, Inc. news
Read company news and market updates connected to Arcus Biosciences, Inc..
Arcus Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Arcus Biosciences, Inc..